keyword
MENU ▼
Read by QxMD icon Read
search

Suerie Moon

keyword
https://www.readbyqxmd.com/read/28332466/towards-a-coherent-global-framework-for-health-financing-recommendations-and-recent-developments
#1
Trygve Ottersen, Riku Elovainio, David B Evans, David McCoy, Di Mcintyre, Filip Meheus, Suerie Moon, Gorik Ooms, John-Arne Røttingen
The articles in this special issue have demonstrated how unprecedented transitions have come with both challenges and opportunities for health financing. Against the background of these challenges and opportunities, the Working Group on Health Financing at the Chatham House Centre on Global Health Security laid out, in 2014, a set of policy responses encapsulated in 20 recommendations for how to make progress towards a coherent global framework for health financing. These recommendations pertain to domestic financing of national health systems, global public goods for health, external financing for national health systems and the cross-cutting issues of accountability and agreement on a new global framework...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332465/the-challenge-of-middle-income-countries-to-development-assistance-for-health-recipients-funders-both-or-neither
#2
Trygve Ottersen, Suerie Moon, John-Arne Røttingen
Recent developments have transformed the role and characteristics of middle-income countries (MICs). Many stakeholders now question the appropriate role of MICs in the system of development assistance for health (DAH), and key funders have already recast their approach to these countries. The pressing question is whether MICs should be recipients, funders, both or neither. The answer has deep implications for individual countries and their citizens, and for the DAH system as a whole. We clarify the fundamental issues involved and emphasise a special feature of many MICs: mid-level gross national income per capita (GNIpc) combined with substantial health needs and large inequalities...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332464/distributing-development-assistance-for-health-simulating-the-implications-of-11-criteria
#3
Trygve Ottersen, Suerie Moon, John-Arne Røttingen
After years of unprecedented growth in development assistance for health (DAH), the DAH system is challenged on several fronts: by the economic downturn and stagnation of DAH, by the epidemiological transition and increase in non-communicable diseases and by the economic transition and rise of the middle-income countries. Central to any potent response is a fair and effective allocation of DAH across countries. A myriad of criteria has been proposed or is currently used, but there have been no comprehensive assessment of their distributional implications...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332463/development-assistance-for-health-critiques-proposals-and-prospects-for-change
#4
Suerie Moon, Oluwatosin Omole
After a 'golden age' of extraordinary growth in the level of development assistance for health (DAH) since 1990, funding seems to have reached a plateau. With the launch of the Sustainable Development Goals, debate has intensified regarding what international financing for health should look like in the post-2015 era. In this review paper, we offer a systematic overview of problems and proposals for change. Major critiques of the current DAH system include: that the total volume of financing is inadequate; financial flows are volatile and uncertain; DAH may not result in additional resources for health; too small a proportion of DAH is transferred to recipient countries; inappropriate priority setting; inadequate coordination; weak mechanisms for accountability; and disagreement on the rationale for DAH...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332462/development-assistance-for-health-what-criteria-do-multi-and-bilateral-funders-use
#5
Trygve Ottersen, Aparna Kamath, Suerie Moon, Lene Martinsen, John-Arne Røttingen
After years of unprecedented growth in development assistance for health (DAH), the system is challenged on several fronts: by the economic downturn and stagnation of DAH, by the epidemiological transition and increase in non-communicable diseases, and by the economic transition and rise of the middle-income countries. This raises questions about which countries should receive DAH and how much, and, fundamentally, what criteria that promote fair and effective allocation. Yet, no broad comparative assessment exists of the criteria used today...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332461/global-public-goods-for-health-weaknesses-and-opportunities-in-the-global-health-system
#6
Suerie Moon, John-Arne Røttingen, Julio Frenk
Since at least the 1990s, there has been growing recognition that societies need global public goods (GPGs) in order to protect and promote public health. While the term GPG is sometimes used loosely to denote that which is 'good' for the global public, we restrict our use of the term to its technical definition (goods that are non-excludable and non-rival in consumption) for its useful analytical clarity. Examples of important GPGs for health include standards and guidelines, research on the causes and treatment of disease, and comparative evidence and analysis...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28115316/post-ebola-reforms-ample-analysis-inadequate-action
#7
Suerie Moon, Jennifer Leigh, Liana Woskie, Francesco Checchi, Victor Dzau, Mosoka Fallah, Gabrielle Fitzgerald, Laurie Garrett, Lawrence Gostin, David L Heymann, Rebecca Katz, Ilona Kickbusch, J Stephen Morrison, Peter Piot, Peter Sands, Devi Sridhar, Ashish K Jha
No abstract text is available yet for this article.
January 23, 2017: BMJ: British Medical Journal
https://www.readbyqxmd.com/read/28099819/powerful-ideas-for-global-access-to-medicines
#8
Suerie Moon
One of the few issues uniting U.S. voters in the 2016 election was outrage over the high prices of medicines. From the quadrupling of EpiPen prices to $1,000-per-pill hepatitis C treatments, from six-digit pricing of cancer drugs to the 55-fold price increase on a 62-year-old toxoplasmosis drug,..
February 9, 2017: New England Journal of Medicine
https://www.readbyqxmd.com/read/27519800/making-technological-innovation-work-for-sustainable-development
#9
Laura Diaz Anadon, Gabriel Chan, Alicia G Harley, Kira Matus, Suerie Moon, Sharmila L Murthy, William C Clark
This paper presents insights and action proposals to better harness technological innovation for sustainable development. We begin with three key insights from scholarship and practice. First, technological innovation processes do not follow a set sequence but rather emerge from complex adaptive systems involving many actors and institutions operating simultaneously from local to global scales. Barriers arise at all stages of innovation, from the invention of a technology through its selection, production, adaptation, adoption, and retirement...
August 30, 2016: Proceedings of the National Academy of Sciences of the United States of America
https://www.readbyqxmd.com/read/27195954/toward-a-common-secure-future-four-global-commissions-in-the-wake-of-ebola
#10
Lawrence O Gostin, Oyewale Tomori, Suwit Wibulpolprasert, Ashish K Jha, Julio Frenk, Suerie Moon, Joy Phumaphi, Peter Piot, Barbara Stocking, Victor J Dzau, Gabriel M Leung
Lawrence Gostin and colleagues offer a set of priorities for global health preparedness and response for future infectious disease threats.
May 2016: PLoS Medicine
https://www.readbyqxmd.com/read/27193334/facing-forward-after-ebola-questions-for-the-next-director-general-of-the-world-health-organization
#11
Devi Sridhar, Ilona Kickbusch, Suerie Moon, Victor Dzau, David Heymann, Ashish K Jha, Jorge Saavendra, Barbara Stocking, Liana Woskie, Peter Piot
No abstract text is available yet for this article.
May 18, 2016: BMJ: British Medical Journal
https://www.readbyqxmd.com/read/26615326/will-ebola-change-the-game-ten-essential-reforms-before-the-next-pandemic-the-report-of-the-harvard-lshtm-independent-panel-on-the-global-response-to-ebola
#12
Suerie Moon, Devi Sridhar, Muhammad A Pate, Ashish K Jha, Chelsea Clinton, Sophie Delaunay, Valnora Edwin, Mosoka Fallah, David P Fidler, Laurie Garrett, Eric Goosby, Lawrence O Gostin, David L Heymann, Kelley Lee, Gabriel M Leung, J Stephen Morrison, Jorge Saavedra, Marcel Tanner, Jennifer A Leigh, Benjamin Hawkins, Liana R Woskie, Peter Piot
No abstract text is available yet for this article.
November 28, 2015: Lancet
https://www.readbyqxmd.com/read/25006088/respecting-the-right-to-access-to-medicines-implications-of-the-un-guiding-principles-on-business-and-human-rights-for-the-pharmaceutical-industry
#13
Suerie Moon
What are the human rights responsibilities of pharmaceutical companies with regard to access to medicines? The state-based international human rights framework has long struggled with the issue of the human rights obligations of non-state actors, a question sharpened by economic globalization and the concomitant growing power of private for-profit actors ("business"). In 2011, after a six-year development process, the UN Human Rights Council unanimously endorsed the Guiding Principles advanced by the UN Secretary General's Special Representative on Business and Human Rights, John Ruggie...
2013: Health and Human Rights
https://www.readbyqxmd.com/read/24524782/the-political-origins-of-health-inequity-prospects-for-change
#14
Ole Petter Ottersen, Jashodhara Dasgupta, Chantal Blouin, Paulo Buss, Virasakdi Chongsuvivatwong, Julio Frenk, Sakiko Fukuda-Parr, Bience P Gawanas, Rita Giacaman, John Gyapong, Jennifer Leaning, Michael Marmot, Desmond McNeill, Gertrude I Mongella, Nkosana Moyo, Sigrun Møgedal, Ayanda Ntsaluba, Gorik Ooms, Espen Bjertness, Ann Louise Lie, Suerie Moon, Sidsel Roalkvam, Kristin I Sandberg, Inger B Scheel
No abstract text is available yet for this article.
February 15, 2014: Lancet
https://www.readbyqxmd.com/read/24393496/who-s-role-in-the-global-health-system-what-can-be-learned-from-global-r-d-debates
#15
REVIEW
Suerie Moon
Recent global debates on the research and development (R&D) of health technologies, such as drugs, diagnostics and vaccines, can be seen as a microcosm of discussions on the role of the World Health Organization (WHO) in the global health system more broadly. The global R&D system has come under heightened scrutiny with the publication of a 2012 report by the WHO Consultative Expert Working Group on Research and Development (CEWG), which made a number of recommendations to more equitably meet global health needs...
February 2014: Public Health
https://www.readbyqxmd.com/read/24388312/from-sovereignty-to-solidarity-a-renewed-concept-of-global-health-for-an-era-of-complex-interdependence
#16
Julio Frenk, Octavio Gómez-Dantés, Suerie Moon
No abstract text is available yet for this article.
January 4, 2014: Lancet
https://www.readbyqxmd.com/read/23465103/governance-challenges-in-global-health
#17
Julio Frenk, Suerie Moon
Global health is at the threshold of a new era. Few times in history has the world faced challenges as complex as those now posed by a trio of threats: first, the unfinished agenda of infections, undernutrition, and reproductive health problems; second, the rising global burden of noncommunicable..
March 7, 2013: New England Journal of Medicine
https://www.readbyqxmd.com/read/22615544/innovation-and-access-to-medicines-for-neglected-populations-could-a-treaty-address-a-broken-pharmaceutical-r-d-system
#18
Suerie Moon, Jorge Bermudez, Ellen 't Hoen
No abstract text is available yet for this article.
2012: PLoS Medicine
https://www.readbyqxmd.com/read/21992405/a-win-win-solution-a-critical-analysis-of-tiered-pricing-to-improve-access-to-medicines-in-developing-countries
#19
Suerie Moon, Elodie Jambert, Michelle Childs, Tido von Schoen-Angerer
BACKGROUND: Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as a way to improve access to medicines for the poor. We carried out case studies based on a review of international drug price developments for antiretrovirals, artemisinin combination therapies, drug-resistant tuberculosis medicines, liposomal amphotericin B (for visceral leishmaniasis), and pneumococcal vaccines...
2011: Globalization and Health
https://www.readbyqxmd.com/read/21439089/driving-a-decade-of-change-hiv-aids-patents-and-access-to-medicines-for-all
#20
REVIEW
Ellen 't Hoen, Jonathan Berger, Alexandra Calmy, Suerie Moon
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to reach more than five million people in developing countries. Essential to this achievement was the dramatic reduction in antiretroviral prices, a result of global political mobilization that cleared the way for competitive production of generic versions of widely patented medicines.Global trade rules agreed upon in 1994 required many developing countries to begin offering patents on medicines for the first time. Government and civil society reaction to expected increases in drug prices precipitated a series of events challenging these rules, culminating in the 2001 World Trade Organization's Doha Declaration on the Agreement on Trade-Related Aspects of Intellectual Property Rights and Public Health...
2011: Journal of the International AIDS Society
keyword
keyword
83612
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"